Follicular Lymphoma

CLINICAL_TRIALS trial_result · 2018-01-25

Clinical Trial Update: Chidamide for Patients With Relapse or Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma [Phase 2]

Phase 2 trial update for chidamide in patients with relapse or refractory diffuse large B-cell lymphoma and follicular lymphoma is ongoing w…

CLINICAL_TRIALS trial_result · 2018-01-09

Clinical Trial Update: Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]

Phase 3 trial comparing Inotuzumab Ozogamicin plus Rituximab vs investigator's choice in follicular lymphoma was terminated with results pos…

CLINICAL_TRIALS trial_result · 2018-01-09

Clinical Trial Update: Combination of Oral Fludarabine, Mitoxantrone Und Rituximab Induction Therapy and Rituximab Maintenance Therapy in Follicular B-Cell Lymphoma [Phase 2]

Phase 2 trial evaluating induction with oral fludarabine, mitoxantrone, and rituximab followed by rituximab maintenance in follicular B-cell…

CLINICAL_TRIALS trial_result · 2017-12-05

Clinical Trial Update: Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma [Phase 2]

Phase 2 trial evaluating rituximab plus GM-CSF in newly diagnosed follicular lymphoma has completed enrollment with results posted.

CLINICAL_TRIALS withdrawal · 2017-12-02

Clinical Trial Update: T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies [Phase 1, Phase 2]

A trial investigating T-regulatory cell and CD3-depleted double umbilical cord blood transplantation for hematologic malignancies has been w…

CLINICAL_TRIALS trial_result · 2017-11-28

Clinical Trial Update: Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

This trial update reports on PET/CT imaging protocol optimization using optimized F18-FDG dosing to minimize radiation exposure while improv…

CLINICAL_TRIALS trial_result · 2017-11-20

Clinical Trial Update: A Phase I Study of Alisertib + R-EPOCH for Treatment of Myc-Positive Aggressive B-cell Lymphomas [Phase 1]

Phase I study of alisertib combined with R-EPOCH for myc-positive aggressive B-cell lymphomas has been terminated.

CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]

This is a Phase 1 clinical trial update for the anti-CD20 antibody ofatumumab in Japanese patients with CD20-positive follicular lymphoma or…

CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma [Phase 3]

Phase 3 trial evaluating low-dose radiation therapy for follicular lymphoma and marginal zone lymphoma has completed.

CLINICAL_TRIALS trial_result · 2017-11-14

Clinical Trial Update: An Observational Study of MabThera/Rituxan (Rituximab) Plus Chemotherapy As First-Line Treatment in Patients With Diffuse Large B-Cell Lymphoma or Follicular Lymphoma

This clinical trial update reports on an observational study of Rituxan/MabThera (rituximab) plus chemotherapy as first-line treatment for d…

CLINICAL_TRIALS trial_result · 2017-11-06

Clinical Trial Update: Safety and Efficacy Study of BCD-020 in Therapy of Indolent Non-Hodgkin's Lymphoma [Phase 3]

Phase 3 trial evaluating BCD-020 for indolent non-Hodgkin lymphomas has completed, assessing safety and efficacy.

CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab

This completed trial evaluated factors associated with hepatitis B reactivation in patients with diffuse large B-cell lymphoma or follicular…

CLINICAL_TRIALS research · 2017-10-24

Clinical Trial Update: Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy [Phase 2]

A Phase 2 clinical trial evaluates the combination of Rituximab with autologous effector lymphocytes in follicular lymphoma patients respond…

CLINICAL_TRIALS trial_result · 2017-10-19

Clinical Trial Update: A Safety Study of SGN-CD19A for B-Cell Lymphoma [Phase 1]

Phase 1 safety study of SGN-CD19A in various B-cell lymphomas has completed; the update summarizes safety results across multiple indication…

CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) [Phase 2]

A Phase 2 trial evaluating venetoclax with BR versus BR or venetoclax with rituximab in relapsed/refractory follicular lymphoma; results pos…

CLINICAL_TRIALS trial_result · 2017-10-09

Clinical Trial Update: Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone Lymphoma [Phase 2]

Phase 2 clinical trial evaluating the combination of pegfilgrastim and rituximab in patients with untreated, relapsed, or refractory follicu…

CLINICAL_TRIALS trial_result · 2017-09-29

Clinical Trial Update: A Phase I/II Study of Intratumoral Injection of SD-101 [Phase 1, Phase 2]

Phase I/II trial investigating intratumoral SD-101 for various B-cell lymphomas; study completed with results posted in 2017.

CLINICAL_TRIALS trial_result · 2017-09-11

Clinical Trial Update: Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma [Phase 1, Phase 2]

Phase 1/2 trial evaluating temsirolimus with bendamustine and rituximab in relapsed follicular lymphoma or mantle cell lymphoma has been com…

CLINICAL_TRIALS research · 2017-08-29

Clinical Trial Update: Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0

This clinical trial update reports on blood immunophenotyping techniques to aid staging of indolent B-cell lymphomas, including Follicular L…

CLINICAL_TRIALS other · 2017-07-31

Clinical Trial Update: Constitutional Genetics in Follicular Lymphoma

This clinical trial update concerns constitutional genetics in follicular lymphoma, with listed conditions including Follicular lymphoma and…

CLINICAL_TRIALS research · 2017-07-19

Clinical Trial Update: Study of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]

Clinical trial update describing a Phase 1/Phase 2 study of CT-1530 in relapsed or refractory B-cell non-Hodgkin lymphoma, chronic lymphocyt…

CLINICAL_TRIALS trial_result · 2017-07-18

Clinical Trial Update: A Study of PCI-32765 (Ibrutinib) in Patients With Refractory Follicular Lymphoma [Phase 2]

A Phase 2 clinical trial of Ibrutinib (PCI-32765) in patients with refractory follicular lymphoma has completed.

CLINICAL_TRIALS trial_result · 2017-07-17

Clinical Trial Update: First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. [Phase 3]

A Phase 3 trial comparing first-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphomas with maintenance therapy; the s…

CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype [Phase 1]

A Phase 1 clinical trial evaluating vaccination with tumor-derived immunoglobulin idiotype for follicular lymphoma has completed.

CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines [Phase 1]

A Phase 1 trial evaluated a tumor-derived immunoglobulin idiotype antigen vaccine for follicular lymphoma. The trial status indicates comple…

Top drugs studied for this disease